Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 11 for:    Recruiting, Enrolling by invitation Studies | Interventional Studies | Glioblastoma | United States | Start date from 08/08/2019 to 12/19/2019
Previous Study | Return to List | Next Study

Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04019002
Recruitment Status : Recruiting
First Posted : July 15, 2019
Last Update Posted : June 17, 2020
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Susan Chang, University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 1, 2022
Estimated Study Completion Date : March 1, 2022